1 December 2022
On the occasion of World AIDS Day 2022, MPP ED Charles Gore announces that WHO’s preferred first-line HIV treatment is now available through our generic partners in over 100 countries and that 20 million people living with HIV are on this treatment.
He also talks about how there is still a big health gap, in particular the number of new HIV infections every year.
“MPP’s recent licence agreement on long-acting pre-exposure prophylaxis drug cabotegravir will potentially be a game changer in preventing these new infections.”
#WorldAIDSDay 2022 ?? Message from MPP’s generic manufacturing partners
#WorldAIDSDay message from the people of Desmond Tutu Health Foundation, #SouthAfrica
Press and Media
The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to and facilitate the development of life-saving medicines for low- and middle-income countries. Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups, and other stakeholders to prioritise and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations.
To date, MPP has signed agreements with 22 patent holders for 13 HIV antiretrovirals, one HIV technology platform, three hepatitis C direct-acting antivirals, a tuberculosis treatment, a cancer treatment, four long-acting technologies, a post-partum haemorrhage medicine, three oral antiviral treatments for COVID-19 and 16 COVID-19 technologies.
MPP was founded by Unitaid, which continues to be MPP’s main funder. MPP’s work on access to essential medicines is also funded by the Swiss Agency for Development and Cooperation (SDC), Government of Canada, the World Intellectual Property Organization (WIPO) and the Government of Flanders. MPP’s activities in COVID-19 are undertaken with the financial support of the Japanese Government, the French Ministry for Europe and Foreign Affairs, the German Agency for International Cooperation, and SDC.